NFL BIOSCIENCES (EPA:ALNFL) | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
NFL BIOSCIENCES

REGULATED PRESS RELEASE

published on 01/09/2024 at 17:45, 1 year 3 months ago

NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
NFL Biosciences, a biopharmaceutical company, has announced its financial communication calendar for 2024, including dates for annual results, Annual General Meeting, and half-year results. The company is known for developing botanical drug candidates for the treatment of addictions, such as NFL-101 for nicotine cessation and NFL-301 for reducing alcohol consumption. For more information, visit www.nflbiosciences.com.

NFL Biosciences Biopharmaceutical Company Financial Calendar 2024 Botanical Drug Candidates Addiction Treatment
REGULATED PRESS RELEASE

published on 01/09/2024 at 17:45, 1 year 3 months ago

NFL BIOSCIENCES : AGENDA DE COMMUNICATION FINANCIÈRE 2024
La société biopharmaceutique NFL BIOSCIENCES annonce son calendrier de communication financière pour l'année 2024, incluant les résultats annuels 2023 et d'autres événements importants

NFL Biosciences Médicaments Botaniques Communication Financière Résultats Annuels Biopharmaceutique
REGULATED PRESS RELEASE

published on 01/08/2024 at 17:45, 1 year 3 months ago

NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ 2ème SEMESTRE 2023
ARTICLE

published on 12/19/2023 at 08:40, 1 year 3 months ago

NFL Biosciences engage le processus d'approbation de la FDA pour son traitement contre l'alcoolisme
NFL Biosciences vise à renforcer sa présence sur le marché pharmaceutique en proposant une nouvelle solution thérapeutique contre la dépendance à l'alcool

NFL Biosciences FDA Pre-IND Consommation Excessive D'alcool Traitement Des Dépendances
REGULATED PRESS RELEASE

published on 12/19/2023 at 08:00, 1 year 3 months ago

NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION
REGULATED PRESS RELEASE

published on 12/19/2023 at 08:00, 1 year 3 months ago

NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDA AUX ÉTATS-UNIS POUR NFL- 301 DÉDIÉ À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL
REGULATED PRESS RELEASE

published on 10/05/2023 at 19:00, 1 year 6 months ago

NFL BIOSCIENCES: 2023 FIRST-HALF BUSINESS AND EARNINGS UPDATE
REGULATED PRESS RELEASE

published on 10/05/2023 at 19:00, 1 year 6 months ago

NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1ER SEMESTRE 2023

Accesswire

Published on 04/12/2025 at 15:45, 1 day 5 hours ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 19 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 21 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 21 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 21 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 23 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 2 days 2 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 2 days 2 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days 3 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 2 days 3 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 2 days 2 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days 2 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days 3 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days 3 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days 3 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE